FDA Inspection 1018556 — Park Infusioncare LP dba Preferred Homecare
The FDA completed an inspection of Park Infusioncare LP dba Preferred Homecare on July 11, 2017 in Dallas, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dallas, TX (United States)